|
20 Sep 2025 |
Jyothy Labs
|
Consensus Share Price Target
|
322.50 |
399.38 |
- |
23.84 |
buy
|
|
|
|
|
07 Feb 2023
|
Jyothy Labs
|
Geojit BNP Paribas
|
322.50
|
247.00
|
207.20
(55.65%)
|
Target met |
Accumulate
|
|
|
|
|
27 Jan 2023
|
Jyothy Labs
|
ICICI Securities Limited
|
322.50
|
250.00
|
203.85
(58.20%)
|
Target met |
Buy
|
|
|
JYL's underlying performance continues to be good – (1) +14% revenue growth YoY (+4% YoY volume growth (ex of HI), 2% reported) with 3 year CAGR of 13% and (2) focus on laying (medium-term) building blocks – rural & LUP focus along with distribution expansion.
|
|
27 Jan 2023
|
Jyothy Labs
|
ICICI Direct
|
322.50
|
215.00
|
204.80
(57.47%)
|
Target met |
Hold
|
|
|
|
|
28 Nov 2022
|
Jyothy Labs
|
Geojit BNP Paribas
|
322.50
|
224.00
|
210.45
(53.24%)
|
Target met |
Accumulate
|
|
|
|
|
15 Nov 2022
|
Jyothy Labs
|
ICICI Securities Limited
|
322.50
|
250.00
|
194.30
(65.98%)
|
Target met |
Buy
|
|
|
JYL's underlying performance continues to be good – (1) +5% YoY volume growth (ex of HI), 1% reported and (2) focus on laying (medium-term) building blocks – rural & LUP focus along with distribution expansion.
|
|
15 Nov 2022
|
Jyothy Labs
|
ICICI Direct
|
322.50
|
205.00
|
194.30
(65.98%)
|
Target met |
Hold
|
|
|
|
|
14 Nov 2022
|
Jyothy Labs
|
Motilal Oswal
|
322.50
|
190.00
|
194.30
(65.98%)
|
Target met |
Neutral
|
|
|
|
|
26 Sep 2022
|
Jyothy Labs
|
ICICI Securities Limited
|
322.50
|
220.00
|
181.00
(78.18%)
|
Target met |
Buy
|
|
|
In India, a ‘growth market’, investors tend to (rightly) ignore short-term profit sacrifice, provided the trajectory of volume outperformance / market share gains is clear (as it’s DCF-accretive).
|
|
01 Aug 2022
|
Jyothy Labs
|
Geojit BNP Paribas
|
322.50
|
198.00
|
181.05
(78.13%)
|
Target met |
Accumulate
|
|
|
|
|
25 Jul 2022
|
Jyothy Labs
|
Motilal Oswal
|
322.50
|
160.00
|
169.30
(90.49%)
|
|
Neutral
|
|
|
|